Skip to main content

Table 1 Clinical characteristics of the HICBs and non-HICBs groups

From: Effect of hemoperfusion with hexadecyl-immobilized cellulose beads on myocardial fatty acid imaging in hemodialysis patients: a case series study

Variables HICBs (n = 12) Non-HICBs (n = 12) p value
Age, years 64.4 ± 9.6 65.0 ± 10.1 0.8857
Male, n (%) 6 (50.0) 6 (50.0) 1.0000
Hemodialysis duration, years 26.3 ± 7.9 20.8 ± 6.7 0.0785
Observation period, months 61.9 ± 16.3 58.0 ± 12.2 0.5120
Diabetes mellitus, n (%) 2 (16.7) 1 (8.3) 0.8913
Dry weight, kg 51.3 ± 9.6 47.13 0.2595
Body mass index, kg/m2 20.5 ± 3.6 19.4 ± 2.5 0.7984
Cardiothoracic rate, % 50.7 ± 4.9 51.7 ± 4.8 0.3092
Systolic blood pressure before dialysis, mmHg 137.6 ± 25.9 140.4 ± 14.1 0.7551
Diastolic blood pressure before dialysis, mmHg 74.8 ± 14.9 75.1 ± 10.3 0.9497
BMIPP summed score at first BMIPP SPECT 6 (3.0–17.5) 6 (2.0–9.5) 0.3645
Hemoglobin, g/dl 10.8 ± 0.5 10.6 ± 0.5 0.4212
Urea nitrogen, mg/dl 57.8 ± 7.12 58.7 ± 7.5 0.7738
Creatinine, mg/dl 9.0 ± 2.3 10.1 ± 2.7 0.3126
Calcium mg/dl 8.7 ± 0.45 8.6 ± 0.6 0.7557
Inorganic phosphorus, mg/dl 5.3 ± 0.8 5.5 ± 0.8 0.4139
Albumin, g/dl 3.7 ± 0.3 3.6 ± 0.44 0.6687
β2-microglobulin, mg/l 23.0 ± 4.6 29.2 ± 5.2 0.0056
C-reactive protein, mg/dl 0.42 (0.14–0.98) 0.58 (0.16–1.1) 0.9310
Parathyroid hormone-intact, pg/ml 88.7 (29.5–166.3) 62.8 (16.3–139.5) 0.3708
Dialysis mode (hemodialysis/hemodiafiltration), n 12/0 10/2 0.4783
Dialysis time, h 4.2 ± 0.4 4.6 ± 0.6 0.0538
Single pool Kt/V urea 1.93 ± 0.27 2.01 ± 0.32 0.5016
Normalized protein catabolism rate, g/kg/day 0.86 ± 0.11 0.89 ± 0.09 0.4212
Geriatric Nutritional Risk Index 92.9 ± 4.2 90.9 ± 9.5 0.5092
Creatinine generation rate, % 93.5 ± 20.8 109.0 ± 26.5 0.1234
Medications
 α1 blockers, n (%) 1 (8.3) 2 (16.7) 0.5371
 β1 blockers, n (%) 1 (8.3) 4 (33.3) 0.1316
 Calcium channel blockers, n (%) 6 (50.0) 7 (58.3) 0.6820
 Nitrates, n (%) 0 (0.0) 0 (0.0)
 Angiotensin-converting enzyme inhibitors, n (%) 1 (8.3) 2 (16.7) 0.5371
 Angiotensin II receptor blockers, n (%) 2 (16.7) 2 (16.7) 1.0000
 Antiplatelet drugs, n (%) 5 (41.7) 3 (25.0) 0.3865
 Stains, n (%) 1 (8.3) 1 (8.3) 1.0000